HRA008206
Title:
Safety and Feasibility of a 41BB Co-stimulated CD19 CAR-NK Cell Therapy in Refractory/relapsed Large B-cell Lymphoma-Supplement
Release date:
2024-11-15
Description:
In this study, we used Single-cell RNA sequencing (scRNA-seq) to test the charactieristic of CARNK infusion product and the PBMCs from patiens.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
diffuse large B-cell lymphoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
1
Contact person:
Qian Wenbin
Email:
qianwb@zju.edu.cn
Description:
1
Individuals & samples
Submitter:   Qian Wenbin / qianwb@zju.edu.cn
Organization:   The Second Affiliated Hospital, Zhejiang University School of Medicine
Submission date:   2024-08-05
Requests:   3